Banks - Regional
Build Your Comparison
Side-by-side financial analysisStock Comparison
BOTJ vs MNSB vs CARE vs FXNC vs NKSH vs KO vs JPM
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
Banks - Regional
Banks - Regional
Banks - Regional
Beverages - Non-Alcoholic
Banks - Diversified
BOTJ vs MNSB vs CARE vs FXNC vs NKSH vs KO vs JPM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||||
|---|---|---|---|---|---|---|---|
| Industry | Banks - Regional | Banks - Regional | Banks - Regional | Banks - Regional | Banks - Regional | Beverages - Non-Alcoholic | Banks - Diversified |
| Market Cap | $112M | $184M | $662M | $273M | $231M | $355.61B | $896.00B |
| Revenue (TTM) | $62M | $135M | $252M | $115M | $85M | $49.28B | $280.33B |
| Net Income (TTM) | $9M | $16M | $31M | $18M | $16M | $13.70B | $57.05B |
| Gross Margin | 77.7% | 54.3% | 61.2% | 74.7% | 65.1% | 61.7% | 60.0% |
| Operating Margin | 18.0% | 14.1% | 15.9% | 19.0% | 22.5% | 29.3% | 25.9% |
| Forward P/E | 12.4x | 11.0x | 5.5x | 12.8x | 11.3x | 25.3x | 14.4x |
| Total Debt | $9M | $70M | $179M | $43M | $2M | $45.49B | $942.38B |
| Cash & Equiv. | $29M | $26M | $105M | $161M | $8M | $10.27B | $343.34B |
BOTJ vs MNSB vs CARE vs FXNC vs NKSH vs KO vs JPM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 20 | Jun 26 | Return |
|---|---|---|---|
| Bank of the James F… (BOTJ) | 100 | 288.2 | +188.2% |
| MainStreet Bancshar… (MNSB) | 100 | 188.9 | +88.9% |
| Carter Bankshares, … (CARE) | 100 | 370.2 | +270.2% |
| First National Corp… (FXNC) | 100 | 217.5 | +117.5% |
| National Bankshares… (NKSH) | 100 | 127.0 | +27.0% |
| The Coca-Cola Compa… (KO) | 100 | 184.9 | +84.9% |
| JPMorgan Chase & Co. (JPM) | 100 | 341.0 | +241.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BOTJ vs MNSB vs CARE vs FXNC vs NKSH vs KO vs JPM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BOTJ is the #2 pick in this set and the best alternative if sleep-well-at-night is your priority.
- Lower volatility, beta 0.15, Low D/E 11.0%, current ratio 496.36x
- Beta 0.15 vs JPM's 0.94, lower leverage
In this particular matchup, MNSB is outpaced on most metrics by others in the set.
CARE ranks third and is worth considering specifically for momentum.
- +79.6% vs KO's +17.2%
FXNC is the clearest fit if your priority is income & stability and growth exposure.
- Dividend streak 11 yrs, beta 0.52, yield 2.0%
- Rev growth 27.1%, EPS growth 96.0%
- NIM 3.6% vs JPM's 2.2%
- 27.1% NII/revenue growth vs MNSB's -1.4%
NKSH is the clearest fit if your priority is defensive.
- Beta 0.73, yield 4.2%, current ratio 1203.84x
- 4.2% yield, vs KO's 2.5%, (1 stock pays no dividend)
KO has the current edge in this matchup, primarily because of its strength in quality and efficiency.
- 27.8% margin vs MNSB's 11.5%
- 13.1% ROA vs CARE's 0.7%, ROIC 15.8% vs 5.7%
JPM is the clearest fit if your priority is long-term compounding and valuation efficiency.
- 465.8% 10Y total return vs FXNC's 258.5%
- PEG 0.81 vs FXNC's 8.59
- Lower P/E (14.4x vs 25.3x), PEG 0.81 vs 2.26
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 27.1% NII/revenue growth vs MNSB's -1.4% | |
| Value | Lower P/E (14.4x vs 25.3x), PEG 0.81 vs 2.26 | |
| Quality / Margins | 27.8% margin vs MNSB's 11.5% | |
| Stability / Safety | Beta 0.15 vs JPM's 0.94, lower leverage | |
| Dividends | 4.2% yield, vs KO's 2.5%, (1 stock pays no dividend) | |
| Momentum (1Y) | +79.6% vs KO's +17.2% | |
| Efficiency (ROA) | 13.1% ROA vs CARE's 0.7%, ROIC 15.8% vs 5.7% |
BOTJ vs MNSB vs CARE vs FXNC vs NKSH vs KO vs JPM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
BOTJ vs MNSB vs CARE vs FXNC vs NKSH vs KO vs JPM — Financial Metrics
Side-by-side numbers across 7 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
KO leads in 2 of 6 categories
BOTJ leads 0 • MNSB leads 0 • CARE leads 0 • FXNC leads 0 • NKSH leads 0 • JPM leads 0 • 4 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
KO leads this category, winning 2 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
JPM is the larger business by revenue, generating $280.3B annually — 4533.1x BOTJ's $62M. KO is the more profitable business, keeping 27.8% of every revenue dollar as net income compared to MNSB's 11.5%.
| Metric | |||||||
|---|---|---|---|---|---|---|---|
| RevenueTrailing 12 months | $62M | $135M | $252M | $115M | $85M | $49.3B | $280.3B |
| EBITDAEarnings before interest/tax | $12M | $23M | $46M | $25M | $20M | $15.5B | $81.4B |
| Net IncomeAfter-tax profit | $9M | $16M | $31M | $18M | $16M | $13.7B | $57.0B |
| Free Cash FlowCash after capex | $10M | $11M | $30M | $21M | $17M | $12.6B | $100.9B |
| Gross MarginGross profit ÷ Revenue | +77.7% | +54.3% | +61.2% | +74.7% | +65.1% | +61.7% | +60.0% |
| Operating MarginEBIT ÷ Revenue | +18.0% | +14.1% | +15.9% | +19.0% | +22.5% | +29.3% | +25.9% |
| Net MarginNet income ÷ Revenue | +14.6% | +11.5% | +12.5% | +15.4% | +18.6% | +27.8% | +20.4% |
| FCF MarginFCF ÷ Revenue | +16.6% | +7.9% | +11.9% | +18.2% | +20.5% | +25.5% | +36.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — | — | +12.1% | — |
| EPS Growth (YoY)Latest quarter vs prior year | +66.7% | +120.9% | +8.3% | +7.1% | +91.7% | +18.2% | +16.0% |
Valuation Metrics
Evenly matched — BOTJ and MNSB each lead in 2 of 7 comparable metrics.
Valuation Metrics
At 12.4x trailing earnings, BOTJ trades at a 54% valuation discount to KO's 27.2x P/E. Adjusting for growth (PEG ratio), BOTJ offers better value at 0.90x vs NKSH's 140.16x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||||
|---|---|---|---|---|---|---|---|
| Market CapShares × price | $112M | $184M | $662M | $273M | $231M | $355.6B | $896.0B |
| Enterprise ValueMkt cap + debt − cash | $93M | $227M | $735M | $155M | $225M | $390.8B | $1.50T |
| Trailing P/EPrice ÷ TTM EPS | 12.44x | 14.16x | 21.34x | 15.40x | 14.59x | 27.18x | 16.00x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 11.03x | 5.47x | 12.82x | 11.28x | 25.27x | 14.40x |
| PEG RatioP/E ÷ EPS growth rate | 0.90x | — | — | 10.32x | 140.16x | 2.43x | 0.90x |
| EV / EBITDAEnterprise value multiple | 7.44x | 11.90x | 18.38x | 7.05x | 11.74x | 26.39x | 18.36x |
| Price / SalesMarket cap ÷ Revenue | 1.80x | 1.35x | 2.60x | 2.43x | 2.71x | 7.42x | 3.20x |
| Price / BookPrice ÷ Book value/share | 1.41x | 0.87x | 1.60x | 1.46x | 1.25x | 10.40x | 2.47x |
| Price / FCFMarket cap ÷ FCF | 10.72x | 17.26x | 20.81x | 12.99x | 15.27x | 67.15x | 8.88x |
Profitability & Efficiency
KO leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
KO delivers a 41.1% return on equity — every $100 of shareholder capital generates $41 in annual profit, vs $7 for MNSB. NKSH carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), CARE scores 8/9 vs JPM's 5/9, reflecting strong financial health.
| Metric | |||||||
|---|---|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +12.1% | +7.3% | +7.6% | +10.0% | +9.0% | +41.1% | +15.9% |
| ROA (TTM)Return on assets | +0.9% | +0.7% | +0.7% | +0.9% | +0.9% | +13.1% | +1.3% |
| ROICReturn on invested capital | +9.7% | +5.0% | +5.7% | +7.7% | +8.4% | +15.8% | +4.5% |
| ROCEReturn on capital employed | +2.0% | +6.0% | +1.5% | +9.9% | +1.9% | +17.3% | +8.9% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 5 | 8 | 7 | 8 | 7 | 5 |
| Debt / EquityFinancial leverage | 0.11x | 0.32x | 0.43x | 0.23x | 0.01x | 1.33x | 2.60x |
| Net DebtTotal debt minus cash | -$20M | $43M | $73M | -$118M | -$6M | $35.2B | $599.0B |
| Cash & Equiv.Liquid assets | $29M | $26M | $105M | $161M | $8M | $10.3B | $343.3B |
| Total DebtShort + long-term debt | $9M | $70M | $179M | $43M | $2M | $45.5B | $942.4B |
| Interest CoverageEBIT ÷ Interest expense | 0.80x | 0.31x | 0.39x | 0.84x | 0.64x | 10.70x | 0.74x |
Total Returns (Dividends Reinvested)
Evenly matched — BOTJ and CARE and JPM each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in JPM five years ago would be worth $21,820 today (with dividends reinvested), compared to $11,813 for MNSB. Over the past 12 months, CARE leads with a +79.6% total return vs KO's +17.2%. The 3-year compound annual growth rate (CAGR) favors BOTJ at 42.8% vs MNSB's 4.2% — a key indicator of consistent wealth creation.
| Metric | |||||||
|---|---|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +34.6% | +26.5% | +54.3% | +24.4% | +12.3% | +20.3% | -0.5% |
| 1-Year ReturnPast 12 months | +75.9% | +37.2% | +79.6% | +57.8% | +42.4% | +17.2% | +21.8% |
| 3-Year ReturnCumulative with dividends | +191.2% | +13.1% | +93.9% | +103.7% | +37.2% | +47.0% | +138.2% |
| 5-Year ReturnCumulative with dividends | +55.8% | +18.1% | +108.0% | +71.0% | +24.3% | +65.6% | +118.2% |
| 10-Year ReturnCumulative with dividends | +155.2% | +135.4% | +141.7% | +258.5% | +54.9% | +121.1% | +465.8% |
| CAGR (3Y)Annualised 3-year return | +42.8% | +4.2% | +24.7% | +26.8% | +11.1% | +13.7% | +33.6% |
Risk & Volatility
Evenly matched — CARE and KO each lead in 1 of 2 comparable metrics.
Risk & Volatility
KO is the less volatile stock with a -0.20 beta — it tends to amplify market swings less than JPM's 0.94 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CARE currently trades 99.6% from its 52-week high vs NKSH's 90.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||||
|---|---|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.15x | 0.60x | 0.58x | 0.52x | 0.73x | -0.20x | 0.94x |
| 52-Week HighHighest price in past year | $26.49 | $25.17 | $29.99 | $30.51 | $40.00 | $84.04 | $337.25 |
| 52-Week LowLowest price in past year | $13.00 | $17.86 | $16.14 | $18.31 | $24.74 | $65.35 | $262.71 |
| % of 52W HighCurrent price vs 52-week peak | +93.5% | +99.0% | +99.6% | +99.0% | +90.8% | +98.3% | +95.1% |
| RSI (14)Momentum oscillator 0–100 | 72.9 | 65.3 | 72.8 | 67.0 | 55.1 | 60.6 | 59.1 |
| Avg Volume (50D)Average daily shares traded | 14K | 45K | 316K | 79K | 49K | 12.7M | 7.0M |
Analyst Outlook
Evenly matched — NKSH and KO each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: MNSB as "Hold", CARE as "Hold", FXNC as "Buy", NKSH as "Buy", KO as "Buy", JPM as "Buy". Consensus price targets imply 5.9% upside for JPM (target: $340) vs -30.4% for FXNC (target: $21). For income investors, NKSH offers the higher dividend yield at 4.16% vs MNSB's 1.60%.
| Metric | |||||||
|---|---|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | Hold | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | — | $28.50 | $21.00 | — | $86.13 | $339.75 |
| # AnalystsCovering analysts | — | 1 | 5 | 1 | 4 | 48 | 61 |
| Dividend YieldAnnual dividend ÷ price | +1.6% | +1.6% | — | +2.0% | +4.2% | +2.5% | +1.9% |
| Dividend StreakConsecutive years of raises | 0 | 0 | 0 | 11 | 0 | 56 | 15 |
| Dividend / ShareAnnual DPS | $0.40 | $0.40 | — | $0.61 | $1.51 | $2.04 | $5.95 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +2.4% | +3.0% | +0.1% | 0.0% | +0.2% | +3.9% |
KO leads in 2 of 6 categories — strongest in Income & Cash Flow and Profitability & Efficiency. 4 categories are tied.
BOTJ vs MNSB vs CARE vs FXNC vs NKSH vs KO vs JPM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is BOTJ or MNSB or CARE or FXNC or NKSH or KO or JPM a better buy right now?
For growth investors, First National Corporation (FXNC) is the stronger pick with 27.
1% revenue growth year-over-year, versus -1. 4% for MainStreet Bancshares, Inc. (MNSB). Bank of the James Financial Group, Inc. (BOTJ) offers the better valuation at 12. 4x trailing P/E, making it the more compelling value choice. Analysts rate First National Corporation (FXNC) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — BOTJ or MNSB or CARE or FXNC or NKSH or KO or JPM?
On trailing P/E, Bank of the James Financial Group, Inc.
(BOTJ) is the cheapest at 12. 4x versus The Coca-Cola Company at 27. 2x. On forward P/E, Carter Bankshares, Inc. is actually cheaper at 5. 5x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: JPMorgan Chase & Co. wins at 0. 81x versus National Bankshares, Inc. 's 140. 16x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — BOTJ or MNSB or CARE or FXNC or NKSH or KO or JPM?
Over the past 5 years, JPMorgan Chase & Co.
(JPM) delivered a total return of +118. 2%, compared to +18. 1% for MainStreet Bancshares, Inc. (MNSB). Over 10 years, the gap is even starker: JPM returned +465. 8% versus NKSH's +54. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — BOTJ or MNSB or CARE or FXNC or NKSH or KO or JPM?
By beta (market sensitivity over 5 years), The Coca-Cola Company (KO) is the lower-risk stock at -0.
20β versus JPMorgan Chase & Co. 's 0. 94β — meaning JPM is approximately -571% more volatile than KO relative to the S&P 500. On balance sheet safety, National Bankshares, Inc. (NKSH) carries a lower debt/equity ratio of 1% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.
05Which is growing faster — BOTJ or MNSB or CARE or FXNC or NKSH or KO or JPM?
By revenue growth (latest reported year), First National Corporation (FXNC) is pulling ahead at 27.
1% versus -1. 4% for MainStreet Bancshares, Inc. (MNSB). On earnings-per-share growth, the picture is similar: MainStreet Bancshares, Inc. grew EPS 210. 0% year-over-year, compared to 1. 5% for JPMorgan Chase & Co.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — BOTJ or MNSB or CARE or FXNC or NKSH or KO or JPM?
The Coca-Cola Company (KO) is the more profitable company, earning 27.
3% net margin versus 11. 5% for MainStreet Bancshares, Inc. — meaning it keeps 27. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: KO leads at 28. 7% versus 14. 0% for MNSB. At the gross margin level — before operating expenses — BOTJ leads at 77. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is BOTJ or MNSB or CARE or FXNC or NKSH or KO or JPM more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, JPMorgan Chase & Co. (JPM) is the more undervalued stock at a PEG of 0. 81x versus National Bankshares, Inc. 's 140. 16x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Carter Bankshares, Inc. (CARE) trades at 5. 5x forward P/E versus 25. 3x for The Coca-Cola Company — 19. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for JPM: 5. 9% to $339. 75.
08Which pays a better dividend — BOTJ or MNSB or CARE or FXNC or NKSH or KO or JPM?
In this comparison, NKSH (4.
2% yield), KO (2. 5% yield), FXNC (2. 0% yield), JPM (1. 9% yield), BOTJ (1. 6% yield), MNSB (1. 6% yield) pay a dividend. CARE does not pay a meaningful dividend and should not be held primarily for income.
09Is BOTJ or MNSB or CARE or FXNC or NKSH or KO or JPM better for a retirement portfolio?
For long-horizon retirement investors, The Coca-Cola Company (KO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.
20), 2. 5% yield, +121. 1% 10Y return). Both have compounded well over 10 years (KO: +121. 1%, CARE: +141. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between BOTJ and MNSB and CARE and FXNC and NKSH and KO and JPM?
These companies operate in different sectors (BOTJ (Financial Services) and MNSB (Financial Services) and CARE (Financial Services) and FXNC (Financial Services) and NKSH (Financial Services) and KO (Consumer Defensive) and JPM (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: BOTJ is a small-cap deep-value stock; MNSB is a small-cap deep-value stock; CARE is a small-cap quality compounder stock; FXNC is a small-cap high-growth stock; NKSH is a small-cap deep-value stock; KO is a large-cap quality compounder stock; JPM is a large-cap deep-value stock. BOTJ, MNSB, FXNC, NKSH, KO, JPM pay a dividend while CARE does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.